Local recurrence after Breast-Conserving therapy in relation to gene expression patterns in a large series of patients
Kreike, B., Halfwerk, H., Armstrong, N., Bult, P., Foekens, J.A., Veltkamp, S.C., Nuyten, D.S.A., Bartelink, H. and van de Vijver, M.J. (2009) Local recurrence after Breast-Conserving therapy in relation to gene expression patterns in a large series of patients. Clinical Cancer Research, 15 (12). pp. 4181-4190.
*No subscription required
Purpose: The majority of patients with early-stage breast cancer are treated with breast-conserving therapy (BCT). Several clinical risk factors are associated with local recurrence (LR) after BCT but are unable to explain all instances of LR after BCT. Here, gene expression microarrays are used to identify novel risk factors for LR after BCT.
Experimental Design: Gene expression profiles of 56 primary invasive breast carcinomas from patients who developed a LR after BCT were compared with profiles of 109 tumors from patients who did not develop a LR after BCT. Both unsupervised and supervised methods of classification were used to separate patients into groups corresponding to disease outcome. In addition, for 15 patients, the gene expression profile in the recurrence was compared with that of the primary tumor.
Results: The two main clusters found by hierarchical cluster analysis of all 165 primary invasive breast carcinomas revealed no association with LR. Predefined gene sets (molecular subtypes and “chromosomal instability” signature) are associated with LR (P = 0.0002 and 0.003, respectively). Significant analysis of microarrays revealed an association between LR and cell proliferation, not captured by histologic grading. Class prediction analysis constructed a gene classifier, which was successfully validated, cross-platform, on an independent data set of 161 patients (log-rank P = 0.041). In multivariate analysis, young age was the only independent predictor of LR.
Conclusions: We have constructed and cross-platform validated a gene expression profile predictive for LR after BCT, which is characterized by genes involved in cell proliferation but not a surrogate for high histologic grade.
|Publication Type:||Journal Article|
|Publisher:||American Association for Cancer research|
|Copyright:||© 2016 American Association for Cancer Research|
|Item Control Page|